SREBF1 and metabolic dysfunction-associated steatotic liver disease: At the same time, another research team confirmed that baicalin ameliorated the symptoms of nonalcoholic fatty liver disease (NAFLD) induced in mice by a high-fat diet (HFD) through AMPK-mediated inhibition of SREBP1 and NF-κB pathways and activation of Nrf2 pathway [100].